AngioDynamics Offers 2,400,000 Shares of Common Stock.QUEENSBURY, N.Y. -- AngioDynamics, Inc. (Nasdaq:ANGO ANGO Algemene Nederlandse Gehandicapten Organisatie (Dutch: Equal Opportunities for Persons with Disabilities) ) today announced that it is offering 2,400,000 shares of its common stock at a public offering price of $24.07 per share. The offering is expected to close on May 30, 2006 and is subject to the satisfaction of customary closing conditions. AngioDynamics has granted the underwriters a 30-day option to purchase up to an additional 360,000 shares of common stock to cover over-allotments, if any. RBC Capital Markets RBC Capital Markets is the corporate and investment banking division of Royal Bank of Canada ("RBC"). Broker dealers Depending on the jurisdiction, the division uses different broker dealer subsidiaries of RBC:
The managing or lead underwriter who maintains the books of securities sold for a new issue. Notes: In other words, this person is the underwriter who "runs" the books. Often the book runner is given credit for the total size of the deal. and lead managing underwriter. Canaccord Adams Inc., First Albany Capital Inc. and KeyBanc Capital Markets are acting as co-managers for the offering. The public offering of AngioDynamics' common stock is being made only by means of a prospectus, copies of which may be obtained, when available, by contacting RBC Capital Markets Corporation at Two Embarcadero Center For the Embarcadero Center complex, see Embarcadero Center Two Embarcadero Center is an office skyscraper located in San Francisco's Financial District. The building is part of the Embarcadero Center, which is a complex of six interconnected buildings and one , Suite 1200, San Francisco, CA, telephone 415-633-8500. This communication shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. About AngioDynamics AngioDynamics, Inc. (www.angiodynamics.com) is a leading provider of innovative medical devices used by interventional radiologists, vascular surgeons and other physicians for the minimally invasive diagnosis and treatment of peripheral vascular disease Peripheral Vascular Disease Definition Peripheral vascular disease is a narrowing of blood vessels that restricts blood flow. It mostly occurs in the legs, but is sometimes seen in the arms. . AngioDynamics, Inc. designs, develops, manufactures and markets a broad line of therapeutic and diagnostic devices that enable interventional physicians, such as interventional radiologists, vascular surgeons and others, to treat peripheral vascular diseases and other non-coronary diseases. The Company's diverse product line includes angiographic products, dialysis products, vascular access products, PTA PTA or parent-teacher association: see parent education. products, oncology products, thrombolytic thrombolytic /throm·bo·lyt·ic/ (throm?bo-lit´ik) dissolving or splitting up a thrombus, or an agent that so acts. thrombolytic 1. dissolving or splitting up a thrombus. 2. an agent that dissolves or splits up a thrombus. products and venous products. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion